NLS Pharmaceutics AG Statistics
Total Valuation
NLSP has a market cap or net worth of $2.48 million. The enterprise value is $3.27 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NLSP has 1.62 million shares outstanding. The number of shares has increased by 29.96% in one year.
| Current Share Class | 1.62M |
| Shares Outstanding | 1.62M |
| Shares Change (YoY) | +29.96% |
| Shares Change (QoQ) | +9.87% |
| Owned by Insiders (%) | 32.35% |
| Owned by Institutions (%) | 4.75% |
| Float | 753,146 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -0.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
| Current Ratio | 0.15 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -27.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -227.76% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 96.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$942,161 |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.31% in the last 52 weeks. The beta is -0.31, so NLSP's price volatility has been lower than the market average.
| Beta (5Y) | -0.31 |
| 52-Week Price Change | -79.31% |
| 50-Day Moving Average | 1.84 |
| 200-Day Moving Average | 4.35 |
| Relative Strength Index (RSI) | 41.96 |
| Average Volume (20 Days) | 31,191 |
Short Selling Information
The latest short interest is 41,768, so 2.57% of the outstanding shares have been sold short.
| Short Interest | 41,768 |
| Short Previous Month | 58,190 |
| Short % of Shares Out | 2.57% |
| Short % of Float | 5.55% |
| Short Ratio (days to cover) | 0.45 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.31M |
| Pretax Income | -12.17M |
| Net Income | -6.60M |
| EBITDA | -6.30M |
| EBIT | -6.31M |
| Earnings Per Share (EPS) | -$6.59 |
Full Income StatementBalance Sheet
The company has $552,758 in cash and $1.71 million in debt, giving a net cash position of -$1.16 million or -$0.72 per share.
| Cash & Cash Equivalents | 552,758 |
| Total Debt | 1.71M |
| Net Cash | -1.16M |
| Net Cash Per Share | -$0.72 |
| Equity (Book Value) | -9.27M |
| Book Value Per Share | -9.40 |
| Working Capital | -6.53M |
Full Balance SheetCash Flow
| Operating Cash Flow | -3.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.92M |
| FCF Per Share | -$2.42 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |